An Educational Resource by
Women's Cancer Initiative - Tata Memorial Hospital
19th June 2020
Radiotherapy vs. Trans-Oral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma (OPSCC): Results of a Randomized Trial
Speaker : Deepanjali Adulkar
Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311)
Speaker : Richa Vaish
Elective neck dissection for salvage laryngectomy: A systematic review and meta-analysis
Speaker : Suhail Sayed
Equivalence randomized trial comparing treatment based on sentinel node biopsy versus neck dissection in operable T1-T2N0 oral and oropharyngeal cancer
Speaker : Vidisha Tuljapurkar
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial
Speaker : Trinanjan Basu
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma
Speaker : Nikhil Pande
Nimotuzumab-cisplatin-radiation Versus Cisplatin-Radiation in HPV Negative Oropharyngeal Cancer
Speaker : Udip Maheshwari
Panel discussion by Prasad Narayan
Moderator : Prasad Narayanan
Immune Checkpoint Inhibitors in Advanced Nasopharyngeal Carcinoma: Beyond an Era of Chemoradiation?
Speaker : Amol Dongre
Palliative chemotherapy in carcinoma nasopharynx
Speaker : Vivek Agarwala
GEM20110714: Final overall survival results of the phase III study of first-line gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma
Speaker : Atul Narayankar
Panel discussion by Rohit Pai
Moderator : Rohit Pai
Recurrence and Quality-of-Life Following Elective Nodal Volume and Dose De-Escalation for Oropharyngeal and Laryngeal Cancer: Initial Results from the Infield Trial
Speaker : Dr. Mukul Roy